AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|
27.6 C
New York
Monday, June 29, 2026

Tag: option

newssourceFORcompanyinformationcontent1releasesmarket

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that a 1-for-8 reverse stock split of its outstanding shares of common stock will be effective at 11:59 pm Eastern Time June 16, 2025.

Thinkific Announces Closing of Secondary Offering of Approximately C$14.5 Million of Rhino Group’s Shares

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, June 13, 2025 /CNW/ - Thinkific Labs Inc. ("Thinkific" or the...

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized...

Form 8.3 – Primary Health Properties

FORM 8.3

Luvme Hair Unveils 2025 Mid-Year Sale Offering Up to $110 Off

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Luvme Hair, a trusted name in premium human hair wigs and clip-in hair extensions, is thrilled to announce its highly anticipated 2025 Mid-Year Sale. This exclusive event offers customers discounts of up to $110 on a wide selection of high-quality wigs. Known for their exceptional craftsmanship, comfort, and natural appearance, Luvme Hair wigs provide the perfect solution for anyone looking to enhance their style effortlessly.

BEST SPAC I Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering

HONG KONG, June 12, 2025 /PRNewswire/ -- BEST SPAC I Acquisition Corp. (the "Company"), a blank check company incorporated as a British Virgin Islands business...

Blue Acquisition Corp. Announces the Pricing of $175,000,000 Initial Public Offering

NEWPORT BEACH, Calif., June 12, 2025 /PRNewswire/ -- Blue Acquisition Corp. (the "Company") announced today the pricing of its initial public offering of 17,500,000...

Santacruz Silver Reports First Quarter 2025 Results

VANCOUVER, BC, June 12, 2025 /CNW/ - Santacruz Silver Mining Ltd. (TSXV:SCZ) (OTCQB:SCZMF) (FSE:1SZ) ("Santacruz" or the "Company") reports its financial and operating results for...

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

HAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently inhibiting its activity, which is required for mast cell function and survival.

SAMBAZON® Launches New Pre-Topped Açaí & Smoothie Bowls for Ultimate Convenience

SAN CLEMENTE, Calif., June 2, 2025 /PRNewswire/ -- SAMBAZON®, the leader of Certified Organic and Fair Trade Açaí products, is excited to announce the launch...

Atrium Mortgage Investment Corporation Announces $30 Million Public Offering of Convertible Unsecured Subordinated Debentures

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025

DBV Technologies participera au prochain congrès EAACI 2025

Châtillon, France, le 12 juin (22:30 CEST) 2025

Orange : Orange émet 750 millions d’euros d’obligations hybrides

Communiqué de presse
Paris, 12 juin 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOption

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers